Antitumor effects of granulocyte-macrophage colony-stimulating factor production by melanoma cells

Cancer Research

Volumn 56, Issue 9, 1996, Pages 2191-2198

  Armstrong, Cheryl A ^b   Botella, Rafael ^a   Galloway, Trephina H ^b   Murray, Nancy ^a   Kramp, Jill M ^b   Song, In Sung ^b   Ansel, John C ^b  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ANIMAL CELL; ANTIGEN PRESENTATION; ANTINEOPLASTIC ACTIVITY; ARTICLE; DENDRITIC CELL; DRUG EFFECT; GENE EXPRESSION; GENE THERAPY; IMMUNOGENICITY; LYMPHOCYTIC INFILTRATION; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE SECTION; TUMOR VOLUME;

ANIMALS; CELL DIVISION; GENE TRANSFER TECHNIQUES; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; MELANOMA, EXPERIMENTAL; MICE; NEOPLASM TRANSPLANTATION; TUMOR CELLS, CULTURED; VACCINATION;

EID: 0029877716     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Mukherji, B., and Chakraborty, N Immunobiology and immunotherapy of melanoma. Curr Opin. Oncol., 7. 175-184, 1995
2. Ettinghousen, S E., and Rosenberg, S A Immunotherapy and gene therapy of cancer Adv Surg., 28 223-254, 1995
3. Dranoff, G., and Mulligan, R C Gene transfer as cancer therapy Adv Immunol , 58: 417-454, 1995.
4. Tepper, R I., and Mule, J J. Experimental and clinical studies of cytokine gene-modified tumor cells. Hum. Gene Ther , 5: 153-164, 1994
5. Miller, A D. Human gene therapy comes of age Nature (Lond. ), 357 445-160, 1992
6. Armstrong, C. A., Murray, N , Kennedy, M., Kopula, S V., Tara, D , and Ansel, J C. Melanoma-derived interleukin 6 inhibits in vivo melanoma growth. J. Invest. Dermatol. 102: 278-284, 1994.
7. Hu, F., Wang, R-Y , and Hsu, T C. Clonal origin of metastasis in B16 murine melanoma: a cytogenetic study. J. Natl. Cancer Inst., 78. 155-163, 1987.
8. Hu, F , and Lesley, P F. The isolation and cytology of two pigment cell strains from B16 mouse melanomas. Cancer Res., 24: 1634-1643, 1964
9. Gough, N. M., Metcalf, D , Gough, J., Grail, D. and Dunn, A R Structure and expression of the mRNA for murine granulocyte-macrophage colony stimulating factor EMBO J., 4: 645-653, 1985.
10. Cepko, C. L., Roberts, B. E., and Mulligan, R. C Construction and applications of a highly transmissible murine retrovirus shuttle vector. Cell, 37: 1053-1062, 1984.
11. London, L., and McKearn, J. P. Activation and growth of colony-stimulating factor-dependent cell lines is cell cycle stage dependent. J. Exp. Med., 166: 1419-1435, 1987.
12. Tomayko, M M , and Reynolds, C. P Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother. Pharmacol., 24: 148-154, 1989.
13. Sander, B., Andersson, J., and Andersson, U. Assessment of cytokines by immunofluorescence and the paraformaldehyde-saponin procedure. Immunol. Rev., 119: 65-93, 1991.
14. Dranoff, G., Jaffee, E., Lazenby, A., Golumbek, P., Levitsky, H , Brose, K., Jackson, V., Hamada, H., Pardoll, D , and Mulligan, R. C. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long lasting anti-tumor immunity. Proc Natl. Acad. Sci. USA, 90. 3539-3543, 1993.
15. Saito, S., Bannerji, R , Gansbacher, B., Rosenthal, F. M , Romanenko, P., Heston, W D W., Fair, W R , and Gilboa, E Immunotherapy of bladder cancer with cytokine gene-modified tumor vaccines Cancer Res. 54: 3516-3520, 1994
16. Vieweg, J., Rosenthal, F. M , Bannerji, R., Heston, W. D W , Fair, W. R., Gansbacher, B., and Gilboa, E. Immunotherapy of prostate cancer in the Dunning rat model: use of cytokine gene modified tumor vaccines. Cancer Res , 54 1760-1765, 1994
17. Golumbek, P. T., Azhari, R., Jaffee, E M., Levitsky, H. I., Lazenby, A., Leong, K., and Pardoll, D. M. Controlled release, biodegradable cytokine depots: a new approach in cancer vaccine design Cancer Res., 53: 5841-5844, 1993.
18. Levitsky, H J., Lazenby, A., Hayashi, R. J., and Pardoll, D. M. In vitro priming of two distinct antitumor effector populations, the role of MHC class I expression. J Exp Med , 179: 1215-1224, 1994.
19. Berns, A J. M., Clift, S., Cohen, L K , Donehower, R. C., Dranoff, G., Hauda, K. M , Jaffee, E M , Lazenby, A. J., Levitsky, H. I., Marshall, F. F., Mulligan, R. C , Nelson, W. G., Owen, A. H., Pardoll, D. M., Parry, G., Partin, A. H., Piantadosi, S., Simons, J W , and Zabora, J. R. Phase I study of non-replicating autologous tumor cell injections using cells prepared with or without GM-CSF gene transduction in patients with metastatic renal cell carcinoma. Hum. Gene Ther., 6. 347-368, 1995.
20. Chachoua, A., Oratz, R., Liebes, L., Alter, R S , Felice, A., Peace, D , Vilcek, J , and Blum, R H. Phase Ib trial of granulocyte-macrophage colony-stimulating factor combined with murine monoclonal antibody R24 in patients with metastatic melanoma J. Immunother , 16: 132-141, 1994
21. Handman, E., and Burgess, A W. Stimulation by granulocyte-macrophage colony stimulating factor of Leishmania tropica killing by macrophases. J. Immunol., 122: 1223-1234, 1979.
22. Ho, J L., Reed, S. G., Wick, E. A., and Giordano, M. Granulocyte-macrophage and macrophage colony-stimulating factors actuate intramacrophage killing of Leishmania mexicana amazonensis. J. Infect. Dis , 162: 224-230, 1990.
23. Lieveld, J. L., Frediani, K E., and Winslow, J. M. Cytokine effects and role of adhesive proteins and Fc receptors in human macrophage mediated antibody dependent cellular cytotoxicity J Cell. Biochem., 45: 381-390, 1991
24. Kushmer, B. H , and Cheung, N K GM-CSF enhances 3F8 monoclonal antibody dependent cellular cytotoxicity against human melanoma and neuroblastoma. Blood, 73: 1936-1941, 1989.
25. Winner-Pack, M D , Olivier, W., Valinsky, J , Schuler, G., and Steinman, R. M Granulocyte-macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells J. Exp. Med., 166. 1484-1498, 1987
26. Heufler, C., Koch, F., and Schuler, G. Granulocyte-macrophage colony-stimulating factor and interleukin-1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells. J Exp. Med , 167: 700-705, 1988.
27. Romani, N , Koide, S , Crowley, M., Witmer-Pack, M., Livingstone, A. M , Fathman, C. G., Inaba, K , and Steinman, R M Presentation of exogenous protein antigens by dendritic cells to T cell clones. J. Exp Med., 169: 1169-1178, 1989
28. Schuler, G , and Steinman, R. M. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro J Exp. Med., 161: 526-546, 1985
29. Sallusto, F , and Lanzavecchia, A Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus IL-4 and downregulated by tumor necrosis factor-α. J. Exp. Med , 179, 1109-1118, 1994.
30. Paglia, P , Girolomom, G , Robbian, F., Granucci, F , and Ricciardi-Castagnoli, P Immortalized dendritic cell line fully competent in antigen presentation initiates primary T cell responses in vivo J Exp Med., 178: 1893-1901, 1993
31. Kaplan, G , Walsh, G , Guido, L S , Meyn, P., Burkhardt, R. A , Abalos, R. M., Barder, J , Frindt, P A , Fajarlo, T. T., Celona, R , and Cohn, Z. A. Novel response of human skin to intradermal recombinant granulocyte-macrophage colony -stimulating factor Langerhans cell recruitment, keratinocyte growth, and enhanced wound healing. J Exp. Med , 175. 1717-1728, 1992.
32. Tazi, A., Bouchonnet, F , Grandsaigne, M., Boumsell, L , Hance, A J., and Soler, P. Evidence that granulocyte macrophage-colony-stimulating factor regulates the distribution and differentiated state of dendritic cells: Langerhans cells in human lung and lung cancers. J. Clin Invest., 91: 566-576, 1993
33. Becker, Y Dendritic cell activity against primary tumors: an overview. In Vivo, 7: 187-191, 1993.
34. Azizi, E , Bucana, C., Goldberg, I., and Kripke, M. I. Perturbation of epidermal Langerhans cells in basal cell carcinomas. Am. J. Dermatopathol , 9: 465-473, 1987.
35. Grabbe, S., Bruvers, S., Gallo, F. L , Knisely, T. L., Nazareno, R., and Granstein, R D. Tumor antigen presentation by murine epidermal cells. J. Immunol., 146: 3656-3661, 1991.
36. Cohen, P J., Cohen, P. A., Rosenberg, S. A., Katz, S I., and Mule, J. J. Murine epidermal Langerhans cells and splenic dendritic cells present tumor-associated antigens to primed T cells. Eur. J. Immunol., 24: 315-319, 1994.
37. Shimizu, J , Suda, T., Yoshioka, T., Kosugi, A., Fujiwara, H., and Hamaoka, T. Induction of tumor-specific in vivo protective immunity by immunization with tumor antigen-puked antigen presenting cells. J. Immunol., 142. 1053-1059, 1991.
38. Larsen, C. P., Ritchie, S. C , Hendrix, R., Linsley, P. S., Hathcock, K. S., Hodes, R. J , Lowry, R. P., and Pearson, T. C. Regulation of immunostimulatory function and costimulatory molecule expression (B7-1 and B7-2) expression on murine dendritic cells. J. Immunol., 152: 5208-5219, 1994.
39. Grabbe, S., Beissert, S , Schwarz, T., and Granstein, R. D. Dendritic cells as initiators of rumor immune responses: a possible strategy for tumor immunotherapy? Immunol. Today, 16. 117-121, 1995.
40. Jiang, W., Swiggad, W. J., Heufler, C., Peng, M., Mirza, A., Steinman, R. M., and Nussenzweig, M C. The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing. Nature (Lond.), 375 151-155, 1995.
41. Ostrand-Rosenberg, S. Tumor immunotherapy: the tumor cell as an antigen-presenting cell. Curr. Opin. Immunol., 6: 722-727, 1994.
42. + T cells by B7-transfected melanoma cells. Science (Washington DC), 259. 368-370, 1993.
43. Chen, L P., Ashe, S., Brady, W. A., Hellstrom, I., Hellstrom, K. E., Ledbetter, J. A., McGowan, P., and Linsley, P. S Costimulation of anti-tumor immunity by the B7 counter receptor for the T lymphocyte molecules CD28 and CTLA4. Cell, 71. 1093-1102, 1992.
44. Baskar, S., Ostrand-Rosenberg, S., Nabavi, N , and Glimcher, L. Constitutive expression B7 restores immunogenicity of tumor cells expressing truncated MHC class II molecules. Proc. Natl. Acad. Sci. USA, 90: 5687-5690, 1993.
45. Huang, A. Y., Golumbek, P., Ahmadzadeh, M., Jaffee, E., Pardoll, D., and Levitsky, H Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science (Washington DC), 264: 961-965, 1994.